HONDMANN, DIRK,VAN TOL, ERIC A.F,GROSS, GABRIELE,SCHOEMAKER, MARIEKE H,LAMBERS, TEARTSE TIM
申请号:
PH12015502100
公开号:
PH12015502100A1
申请日:
2015.09.14
申请国别(地区):
PH
年份:
2016
代理人:
摘要:
The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.